Contaminants and Novel Approaches in Food Analysis

Feb 17, 2016 | Blogs, Food / Beverage | 0 comments

During RAFA 2015New Food Magazine hosted a roundtable (sponsored by SCIEX) to bring together experts with routine food testing backgrounds to discuss the latest industry trends, challenges, recent technological advances, and expectations of future laboratories.

Both Vincent Paez, Senior Director of Food Testing and Andre Schreiber, Technical Applications Manager from SCIEX were in attendance and contribute with their extensive experience of working with and supporting routine testing laboratories, as well as developing advanced workflows on the forefront of food safety. 

The roundtable began with a simple question, “In the next 10 years what key changes do you see happening in the food and beverage industry in terms of food analysis?” A detailed discussion followed which covered the aspects of commercial laboratory testing, university laboratory research, the rise of digital technologies and the simplification of processes – in particular, the importance of informatics.

If you are interested in learning more about what each of the speakers had to say we have embedded the full 51-minute roundtable for you to watch below. 

Be sure to leave a comment below and share your thoughts on the questions asked as part of the discussion, or raise any questions you would like to be included in future roundtables!

Also, if you’re interested in watching more from RAFA 2015, check out Andre’s seminar titled “Igniting Your Routine Testing Methods.”

 

PFAS testing: 2024 in review and what to expect for 2025

For as long as PFAS persist in the environment, there is no doubt they will persist in our conversations as environmental scientists. Globally, PFAS contamination has been detected in water supplies, soil and even in the blood of people and wildlife. Different countries are at various stages of addressing PFAS contamination and many governments have set regulatory limits and are working on assessing the extent of contamination, cleaning up affected sites and researching safer alternatives.

Inside the box: Acoustic ejection mass spectrometry for drug discovery

On average, it takes 10-15 years and 1-2 billion dollars to approve a new pharmaceutical for clinical use. Since approximately 90% of new drug candidates fail in clinical development, the ability to make early, informed and accurate decisions on the safety and efficacy of new hits and leads is key to increasing the chances of success.

Unveiling the power of ZT Scan DIA: Insights from Ludwig Sinn’s presentation at World HUPO Congress 2024

In a recent presentation at the World HUPO Congress 2024, Ludwig Sinn from the Ralser lab shared exciting advancements in proteomics research, focusing on the innovative ZT Scan DIA acquisition modes developed in collaboration with SCIEX. Let us explore the key highlights and benefits of this innovative technology.

Posted by

0 Comments

Submit a Comment

Wordpress Social Share Plugin powered by Ultimatelysocial